Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

GUANFACINE vs GUSELKUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

GUANFACINE vs GUSELKUMAB: Safety Overview

Metric GUANFACINE GUSELKUMAB
Total FAERS Reports 3,538 27,987
Deaths Reported 122 364
Death Rate 3.4% 1.3%
Hospitalizations 821 2,031
Average Patient Age 17.8 yrs 52.6 yrs
% Female Patients 34.1% 57.6%
FDA Approval Date Apr 15, 2025 N/A
Manufacturer Coupler LLC Janssen Biotech, Inc.
Route ORAL SUBCUTANEOUS
Marketing Status Discontinued Prescription